Peter Lutwyche BSc, PhD

Peter most recently served as Chief Technology Officer at Arbutus Biopharma Corporation where he led the development of the company’s nucleic acid-delivery technology. Earlier in his career, he was Head of Pharmaceutical Development at QLT where he contributed to the development and commercialization of VISUDYNE. Peter has over 20 years of experience in the field of nucleic acid-based products.